|
ZSCAN5A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.34097202628436E-14 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.63014046705712E-12 |
| Normal-vs-Stage2 |
1.06050000003854E-07 |
| Normal-vs-Stage3 |
1.372190E-04 |
| Normal-vs-Stage4 |
6.4087000040125E-08 |
| Stage1-vs-Stage2 |
4.828600E-01 |
| Stage1-vs-Stage3 |
3.071600E-01 |
| Stage1-vs-Stage4 |
7.011600E-01 |
| Stage2-vs-Stage3 |
8.402800E-01 |
| Stage2-vs-Stage4 |
3.340800E-01 |
| Stage3-vs-Stage4 |
4.057600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.10382880192628E-15 |
| Normal-vs-AfricanAmerican |
4.42720005100483E-09 |
| Normal-vs-Asian |
6.52980000070968E-08 |
| Caucasian-vs-AfricanAmerican |
4.289200E-01 |
| Caucasian-vs-Asian |
2.152400E-01 |
| AfricanAmerican-vs-Asian |
2.069800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.6295853555448E-12 |
| Normal-vs-Female |
3.96379995493135E-09 |
| Male-vs-Female |
4.601700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.5382000075972E-09 |
| Normal-vs-Extreme_Weight |
1.62991842245219E-12 |
| Normal-vs-Obese |
2.10299999636732E-09 |
| Normal-vs-Extreme_Obese |
1.389690E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.807200E-01 |
| Normal_Weight-vs-Obese |
6.020800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.922000E-01 |
| Extreme_Weight-vs-Obese |
1.040420E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.973000E-01 |
| Obese-vs-Extreme_Obese |
4.778200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.151600E-02 |
| Normal-vs-Age(41-60Yrs) |
6.0240701316161E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62625468647093E-12 |
| Normal-vs-Age(81-100Yrs) |
7.32479965570576E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.979600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.935600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.833700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.215600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.308040E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.859400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.63269398001376E-12 |
| Normal-VS-Type2 PRCC |
8.4821039081362E-14 |
| Normal-VS-KIRP CIMP |
1.549820E-01 |
| Normal-VS-Unclassified PRCC |
1.02960000003538E-06 |
| Type1 PRCC-VS-Type2 PRCC |
4.593600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.571570E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.042600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.865700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.173600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.457200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.06110026215833E-10 |
| Normal-vs-N1 |
2.438000E-03 |
| Normal-vs-N2 |
1.97685999999697E-05 |
| N0-vs-N1 |
1.444040E-01 |
| N0-vs-N2 |
4.310600E-01 |
| N1-vs-N2 |
2.038200E-01 |
|
|
